Enzymit

Enzymit is at the forefront of revolutionizing bioproduction, with a focus on making the process faster, simpler, cost-effective, and sustainable. The company's unique approach involves designing and creating novel enzymes to streamline production processes and reduce costs while promoting sustainability. By leveraging cell-free, synthetic biology bioproduction, Enzymit aims to surpass the limitations of fermentation-based methods, thereby meeting the evolving demands of various industries. Established in 2020 by a team of computational science experts, Enzymit stands out for its utilization of deep learning algorithms and high-throughput testing methods to develop novel enzymes for applications in fine chemical manufacturing, foodtech, health, biodefense, and more. Its strategic collaborations with global manufacturers across multiple industries further solidify the company's position for expansion and market impact. The latest milestone for Enzymit includes an investment of $500.00K in non-equity assistance, secured on 01 November 2022, with the backing of the Israel Innovation Authority. With its innovative approach and strategic partnerships, Enzymit is poised to make significant strides in the biotechnology industry from its headquarters in Israel.